Alliance Pharma Share News (APH)

26 Oct 2012

In a deal announced after Thursday's close, Ian Hunter, the Investment Marketing Director of financial services provider Hargreaves Lansdown, has pock...

22 Oct 2012

888 Holdings: Morgan Stanley ups target from 125p to 130p, overweight rating kept. Aggreko: Jefferies cuts target from 2,800p to 2,535p, buy rating k...

19 Oct 2012

Angel Biotech has seen a continuation of the 'very difficult' market conditions since mid-September, with funding constraints of clients forcing delay...

19 Oct 2012

Aggreko: Jefferies keeps buy rating and 2,800p target; Seymour Pierce keeps buy rating and 2,500p target; Panmure Gordon cuts target from 2,228p to 2,...

12 Sep 2012

Alliance Pharma, a specialist pharmaceutical firm, reported a decline in half year pre-tax profit after revenue fell on the back of a 10% drop in sale...

10 Jul 2012

Gresham Computing has unveiled Australia and New Zealand Banking Group as its partner in a previously announced significant contract win. Under the de...

27 Jun 2012

Alliance Pharma: Investec downgrades from buy to hold, target slashed from 34p to 25p. APR Energy: Credit Suisse keeps outperform rating and 1,300p t...

16 Jan 2012

Speciality pharmaceutical company Alliance Pharma has this morning announced its pre-close trading update for the year ended on the 31st of December o...